APXI APx Acquisition Corp. I
- 11.450
- -0.010-0.09%
APx Acquisition Corp. I News
APx Acquisition Corp. I Announces Strategic Triple Merger
OmnigenicsAI Set to Go Public via SPAC Merger Agreement
APx Acquisition I: Deal Values OmnigenicsAI and MultiplAI at a Combined Enterprise Value of Approx $340M at Signing >APXI
APx Acquisition I: Deal Values OmnigenicsAI and MultiplAI at a Combined Enterprise Value of Approx $340M at Signing >APXI
APx Acquisition I Transaction Is Expected to Close Mid-Yr, Subject to the Approval of APx's Hldrs >APXI
APx Acquisition I Transaction Is Expected to Close Mid-Yr, Subject to the Approval of APx's Hldrs >APXI
APx Acquisition I: OmnigenicsAI's Shrs Are Expected to Be Listed on Nasdaq Under the Ticker Symbol OMNI >APXI
APx Acquisition I: OmnigenicsAI's Shrs Are Expected to Be Listed on Nasdaq Under the Ticker Symbol OMNI >APXI
APx Acquisition I: Upon Closing, Combination Would Result in OmnigenicsAI Becoming a Publicly Listed Co >APXI
APx Acquisition I: Upon Closing, Combination Would Result in OmnigenicsAI Becoming a Publicly Listed Co >APXI
Press Release: APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd Enter Into Business Combination Agreement to Create a Global AI-driven Genomics Platform
APx Acquisition Corp. I, OmnigenicsAI Corp and MultiplAI Health Ltd enter into Business Combination Agreement to create a global AI-driven genomics platform PR Newswire NASHVILLE, Tenn., March 26, 2
APX Acquisition Corp. I Gets Deficiency Letter From Nasdaq
Express News | Px Acquisition Corp. I Announced That It Received A Deficiency Letter On Dec. 21, 2023 From The Listing Qualifications Department Of The Nasdaq Stock Market; Notice For Late Filing Of Its Form 10-Q
APx Acquisition I Has Until Feb 19 to Submit a Plan to Regain Compliance With Respect to Delinquent Reports >APXI
APx Acquisition I Has Until Feb 19 to Submit a Plan to Regain Compliance With Respect to Delinquent Reports >APXI
Press Release: APX Acquisition Corp. I Receives Nasdaq Notice on Late Filing of Its Form 10-Q
APX Acquisition Corp. I receives Nasdaq notice on late filing of its Form 10-Q PR Newswire NASHVILLE, Tenn., Dec. 28, 2023 NASHVILLE, Tenn., Dec. 28, 2023 /PRNewswire/ -- APX Acquisition Corp. I (N
APX Acquisition Corp. I Y Bioceres Group Anuncian Una Carta De Intención Para Una Combinación Empresarial Con Una Empresa De Servicios De Bienestar Y Diagnóstico De Medicina De Precisión
NASHVILLE, Tennessee, 4 de diciembre de 2023 /PRNewswire/ -- APX Acquisition Corp. I (NASDAQ: APXI) ("la Empresa"), una empresa de adquisición con fines especiales que cotiza en bolsa, anunció hoy
Press Release: APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination With a Precision Medicine Diagnostic and Wellness Services Company
APX Acquisition Corp. I & Bioceres Group Announce Letter of Intent for a Business Combination with a Precision Medicine Diagnostic and Wellness Services Company PR Newswire NASHVILLE, Tenn., Dec. 1,
APx Acquisition Corp. I Ownership Dominated by Private and Institutional Investors
APx Acquisition Corp. I Announces Additional Contribution to Trust Account to Extend Combination Period
NEW YORK--(BUSINESS WIRE)--APx Acquisition Corp. I ("APx" or the "Company"), a special purpose acquisition company, announced today that the Company deposited into the trust account, established in co
Lynwood Capital Management Inc. Sells 42,200 Shares of APx Acquisition Corp. I (NASDAQ:APXI)
Lynwood Capital Management Inc. lessened its position in APx Acquisition Corp. I (NASDAQ:APXI – Get Rating) by 56.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The
APx Acquisition Corp. I (NASDAQ:APXI) Short Interest Update
APx Acquisition Corp. I (NASDAQ:APXI – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 7,500 shares,
P Schoenfeld Asset Management LP Sells 130,529 Shares of APx Acquisition Corp. I (NASDAQ:APXI)
P Schoenfeld Asset Management LP cut its stake in APx Acquisition Corp. I (NASDAQ:APXI – Get Rating) by 40.9% in the 3rd quarter, according to its most recent filing with the Securities and Exchange
APx Acquisition Corp. I Announces Contribution to Trust Account to Extend Combination Period
NEW YORK--(BUSINESS WIRE)--APx Acquisition Corp. I ("APx" or the "Company"), a special purpose acquisition company, announced today that the Company deposited into the trust account, established in co
APx Acquisition Corp. I Announces Approval of Extension Meeting Proposals and Intention to Extend Combination Period
APx Acquisition Corp. I ("APx" or the "Company"), a special purpose acquisition company, announced today that at the extraordinary general shareholders meeting held on February 27, 2023, the Company's shareholders voted
Analysis
Price Target
No Data
